...
首页> 外文期刊>International Journal of Pharmaceutical and Life Sciences >Formulation and Evaluation of Stavudine Loaded Polymethacrylic Acid Nanoparticles
【24h】

Formulation and Evaluation of Stavudine Loaded Polymethacrylic Acid Nanoparticles

机译:司他夫定负载的聚甲基丙烯酸纳米粒子的制备与评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Nanoparticles represent a promising drug delivery system of controlled and targeted drug release. They are specially designed to release the drug in the vicinity of target tissue. The aim of this study was to prepare and evaluate polymethacrylic acid nanoparticles containing stavudine in different drug to polymer ratio by nanoprecipitation method to be 121 + 8 to 403 + 4 nm. The particle size of the nanoparticles was gradually increased with increase in the proportion of polymethacrylic acid polymer. The drug content of the nanoparticles was increasing on increasing polymer concentration up to a particular concentration. No appreciable difference was observed in the extent of degradation of product during 60 days in which, nanoparticles were stored at various temperatures. FT-IR studies indicated that there was no chemical interaction between drug and polymer and stability of drug. The in-vitro release behavior from all the drug loaded batches was found to be zero order and provided sustained release over a period of 24 h. The developed formulation overcome and alleviates the drawbacks and limitations of stavudine sustained release formulations and could possibility be advantageous in terms of increased bioavailability of stavudine. DOI: http://dx.doi.org/ International Journal of Pharmaceutical and Life Sciences Volume 2, Issue 4: October 2013; 133-140
机译:纳米颗粒代表了有控制的和靶向的药物释放的有前途的药物递送系统。它们是专门设计用于在目标组织附近释放药物的。本研究的目的是通过纳米沉淀法制备和评价含有司他夫定的不同药物与聚合物比例的聚甲基丙烯酸纳米颗粒,其粒径为121 + 8至403 + 4 nm。随着聚甲基丙烯酸聚合物的比例增加,纳米颗粒的粒径逐渐增加。随着聚合物浓度增加至特定浓度,纳米颗粒的药物含量增加。在60天内,在不同温度下存储纳米颗粒的产物的降解程度没有观察到明显差异。 FT-IR研究表明,药物与聚合物之间没有化学相互作用以及药物的稳定性。发现所有载药批次的体外释放行为为零级,并在24小时内提供持续释放。开发的制剂克服并减轻了司他夫定缓释制剂的缺点和局限性,并且在增加司他夫定的生物利用度方面可能是有利的。 DOI:http://dx.doi.org/国际药学与生命科学杂志第2卷,第4期:2013年10月; 133-140

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号